Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
_460x368.jpg)
In December 2023, Occam placed Dr. Rajiv Patni as Strategic Clinical Advisor to CEO Vimal Mehta and the Board of Directors at BioXcel Therapeutics.
Dr. Patni served as Chief Research and Development Officer at Reata Pharmaceuticals, a commercial-stage firm recently acquired by Biogen. Prior to that, he experienced substantial success as CMO of multiple public small-cap, commercial-stage biopharma companies, including Adamas, Portola, and Global Blood Therapeutics. He joined these companies at a turning point in their R&D growth trajectories and contributed to their acquisition by larger firms. Earlier in his career, Dr. Patni had roles of increasing responsibility at Pfizer, Roche, and Actelion.
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. Occam is a leader in recruiting artificial intelligence and machine learning talent for the life sciences, having partnered with insitro, Recursion, GSK, Atomic AI, Relation, Chemify, LabGenius, Nucleome, Charm Therapeutics, Anagenex, and ZebiAI.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.